Brand-name Drugs Increase Cost but Not Patient Satisfaction

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:79 / +
页数:2
相关论文
共 50 条
  • [1] SUBSTITUTION FOR BRAND-NAME DRUGS
    CAMINETSKY, S
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1963, 88 (18) : 950 - &
  • [2] Brand-Name Versus Generic Drugs
    Manning, Richard
    Smith, Richard
    [J]. HEALTH AFFAIRS, 2011, 30 (10) : 2027 - 2027
  • [3] Novelty of Active Ingredients in High-Cost Brand-Name Drugs
    Jung, Emily H.
    Sarpatwari, Ameet
    Kesselheim, Aaron S.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (07) : 2219 - 2221
  • [4] Novelty of Active Ingredients in High-Cost Brand-Name Drugs
    Emily H. Jung
    Ameet Sarpatwari
    Aaron S. Kesselheim
    [J]. Journal of General Internal Medicine, 2020, 35 : 2219 - 2221
  • [5] The Value of Specifying Brand-name Antiepileptic Drugs
    Ng, Yu-tze
    [J]. ARCHIVES OF NEUROLOGY, 2009, 66 (11) : 1415 - 1416
  • [6] ELDERLY, POOR, AND LOYAL TO BRAND-NAME DRUGS
    RICE, B
    [J]. PSYCHOLOGY TODAY, 1980, 14 (04) : 27 - 28
  • [7] Brand-name biologic drugs protected by USMCA
    Mullin, Emily
    [J]. CHEMICAL & ENGINEERING NEWS, 2018, 96 (41) : 19 - 19
  • [8] UNIFORM APPEARANCE OF GENERIC AND BRAND-NAME DRUGS
    KAHN, BS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (26): : 1492 - 1492
  • [9] Inadequate labels: Brand-name and generic drugs
    Kazhdan, Daniel
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [10] Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing
    Bai, Ge
    Sen, Aditi P.
    Anderson, Gerard F.
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 168 (06) : 436 - +